Dion F. Coakley
Nessuna posizione attualmente
Storia della carriera di Dion F. Coakley
Precedenti posizioni note di Dion F. Coakley
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - | - |
| Burroughs Wellcome | Corporate Officer/Principal | - | - |
| HYPERION THERAPEUTICS INC | Direttore Tecnico/Scientifico/R&S | 25/03/2010 | - |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Direttore Tecnico/Scientifico/R&S | 01/03/2007 | - |
Formazione di Dion F. Coakley
| University of Washington | Doctorate Degree |
| The University of Arkansas | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Regno Unito | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
| Burroughs Wellcome | |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
- Borsa valori
- Insiders
- Dion F. Coakley
- Esperienza
